147 related articles for article (PubMed ID: 23553793)
1. Peptidyl cyclopropenones: reversible inhibitors, irreversible inhibitors, or substrates of cysteine proteases?
Cohen M; Bretler U; Albeck A
Protein Sci; 2013 Jun; 22(6):788-99. PubMed ID: 23553793
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of cysteine proteases by peptidyl epoxides: characterization of the alkylation sites on the enzyme and the inactivator.
Albeck A; Kliper S
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):71-6. PubMed ID: 10657241
[TBL] [Abstract][Full Text] [Related]
3. Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities.
Ando R; Sakaki T; Morinaka Y; Takahashi C; Tamao Y; Yoshii N; Katayama S; Saito K; Tokuyama H; Isaka M; Nakamura E
Bioorg Med Chem; 1999 Apr; 7(4):571-9. PubMed ID: 10353636
[TBL] [Abstract][Full Text] [Related]
4. Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.
Perlman N; Hazan M; Shokhen M; Albeck A
Bioorg Med Chem; 2008 Oct; 16(19):9032-9. PubMed ID: 18789705
[TBL] [Abstract][Full Text] [Related]
5. eta(1)-N-succinimidato complexes of iron, molybdenum and tungsten as reversible inhibitors of papain.
Rudolf B; Salmain M; Martel A; Palusiak M; Zakrzewski J
J Inorg Biochem; 2009 Aug; 103(8):1162-8. PubMed ID: 19616302
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
7. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
Löser R; Gütschow M
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
[TBL] [Abstract][Full Text] [Related]
8. Cysteine proteases such as papain are not inhibited by substrate analogue peptidyl boronic acids.
Martichonok V; Jones JB
Bioorg Med Chem; 1997 Apr; 5(4):679-84. PubMed ID: 9158866
[TBL] [Abstract][Full Text] [Related]
9. The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
Valente C; Moreira R; Guedes RC; Iley J; Jaffar M; Douglas KT
Bioorg Med Chem; 2007 Aug; 15(15):5340-50. PubMed ID: 17532221
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of papain inhibition by peptidyl aldehydes.
Shokhen M; Khazanov N; Albeck A
Proteins; 2011 Mar; 79(3):975-85. PubMed ID: 21181719
[TBL] [Abstract][Full Text] [Related]
11. A novel transglutaminase substrate from Streptomyces mobaraensis inhibiting papain-like cysteine proteases.
Sarafeddinov A; Arif A; Peters A; Fuchsbauer HL
J Microbiol Biotechnol; 2011 Jun; 21(6):617-26. PubMed ID: 21715969
[TBL] [Abstract][Full Text] [Related]
12. A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.
Kathman SG; Xu Z; Statsyuk AV
J Med Chem; 2014 Jun; 57(11):4969-74. PubMed ID: 24870364
[TBL] [Abstract][Full Text] [Related]
13. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J
Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606
[TBL] [Abstract][Full Text] [Related]
14. Cys25-nitrosylation inactivates papain.
Venturini G; Fioravanti E; Colasanti M; Persichini T; Ascenzi P
Biochem Mol Biol Int; 1998 Oct; 46(2):425-8. PubMed ID: 9801811
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases.
Redzynia I; Ljunggren A; Bujacz A; Abrahamson M; Jaskolski M; Bujacz G
FEBS J; 2009 Feb; 276(3):793-806. PubMed ID: 19143838
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of cysteine proteases.
Govardhan CP; Abeles RH
Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor.
Assis DM; Gontijo VS; de Oliveira Pereira I; Santos JA; Camps I; Nagem TJ; Ellena J; Izidoro MA; dos Santos Tersariol IL; de Barros NM; Doriguetto AC; dos Santos MH; Juliano MA
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):661-70. PubMed ID: 22468751
[TBL] [Abstract][Full Text] [Related]
18. Quantifying tetrahedral adduct formation and stabilization in the cysteine and the serine proteases.
Cleary JA; Doherty W; Evans P; Malthouse JP
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1382-91. PubMed ID: 26169698
[TBL] [Abstract][Full Text] [Related]
19. Cysteine protease inhibitors containing small rings.
Schirmeister T; Klockow A
Mini Rev Med Chem; 2003 Sep; 3(6):585-96. PubMed ID: 12871161
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks.
Schirmeister T
Biopolymers; 1999; 51(1):87-97. PubMed ID: 10380356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
